Two targets (sTNF-R and TNF-a) were identified for Ang2, six targets (IL-12, sTNF-R, IFN-gama, TNF-a and TF) were selected for Thrombosis, and two targets (C3b and C5b) were selected for MAC. No single perturbation displayed an impact on Phagocytosis based on our evaluation criteria. The gene discussed is ANGPT2; the disease is Venous thrombosis.